High rates of appropriate therapy in non-ischaemic cardiomyopathy patients with implantable cardioverter-defibrillators over a 5-year follow up
Introduction: The benefit of implantable cardioverter defibrillators in non-ischaemic dilated cardiomyopathy (NIDCM) has been convincingly established, however, recent data has suggested a decline in device therapy rates. Evaluation in device therapy between primary and secondary prevention is also...
Saved in:
Published in | European journal of arrhythmia & electrophysiology Vol. 5; p. 200 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Reading
Touch Medical Media Limited
01.01.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!